WHO ICTRP trial
L-carnitine on spirometry in hemodialysis
IRCT20161219031464N3 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT20161219031464N3 |
|---|---|
| Public title | L-carnitine on spirometry in hemodialysis |
| Scientific title | The effect of L-carnitine on ergo spirometry test results in chronic hemodialysis patients |
| Primary sponsor | Shahid Beheshti University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Relationship between L-carnitine and ergospirometric test results in chronic hemodialysis patients. |
| Interventions | Intervention 1: Intervention group1: Each patient receives two grams of l-carnitine tablets (2*1) daily for three months. Intervention 2: Control group: Each patient receives two tablets (placebo) daily similar to L-carnitine. |
| Registration date | Aug 29, 2019 |
| Target size | 40 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: